Physician profile
Ronald E Taylor
NPI 1376631770
$679.00
in general payments reported to CMS, 2019-2025
19 companies · $65.50 in 2025
The $65.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.82 · 2020: $175 · 2021: $200 · 2022: $28.07 · 2023: $122 · 2024: $46.24 · 2025: $65.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $133.39 | 2020-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $80.54 | 2020-2021 | |
| Amarin Pharma, INC. | $53.88 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $50.59 | 2020-2021 | |
| Glaxosmithkline, LLC. | $46.03 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $45.95 | 2021-2023 | Vraylar |
| Allergan, INC. | $38.73 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $36.53 | 2020-2021 | |
| Amgen INC. | $27.23 | 2021-2025 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.32 | 2020-2021 | |
| Insulet Corporation | $20.38 | 2025 | Omnipod |
| Lilly USA, LLC | $17.77 | 2024 | Jardiance, Zepbound |
| Astellas Pharma US INC | $17.51 | 2023 | Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.77 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $14.57 | 2021 | |
| Exact Sciences Corporation | $14.57 | 2023 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $11.71 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.